EDB unveils EDB Postgres AI infoworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infoworld.com Daily Mail and Mail on Sunday newspapers.
Bimekizumab treatment led to superior improvements in joint and skin efficacy outcomes
at week 16 compared with placebo in patients with psoriatic arthritis and inadequate
response or intolerance to TNFα inhibitors. The safety profile of bimekizumab was
consistent with previous phase 3 studies in patients with plaque psoriasis, and studies
of IL-17A inhibitors.